VNRX Stock Analysis: Buy, Sell, or Hold?
VNRX - VolitionRX Limited Common Stock
$0.50
0.16 (47.70%)
▲
5d:
+12.74%
30d:
-35.15%
90d:
-82.6%
HOLD
LOW Confidence
Analysis Updated: Aug 27, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When VNRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VNRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: VNRX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: VNRX is currently trading at $0.50, which is considered slightly low relative to its 30-day fair value range of $0.48 to $0.94. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.6) compared to its historical average (0.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VNRX is in a downtrend. Immediate support is located at $0.33, while resistance sits at $0.72. The stock is showing strong short-term momentum, up 47.7% recently.
Market Sentiment: VNRX scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $16.57 (+3206.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VNRX is in a downtrend. Immediate support is located at $0.33, while resistance sits at $0.72. The stock is showing strong short-term momentum, up 47.7% recently.
Market Sentiment: VNRX scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $16.57 (+3206.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.48 -
$0.94
Company Quality Score
55/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
95.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: Strong upward momentum (+47.7%)
- BULLISH: Trading 3206.6% below Wall St target ($16.57)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 44% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.48 -
$0.94
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.33
Resistance Level
$0.72
Current Trend
Downtrend
Technical data as of
Aug 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.59
Wall Street Target
$16.57
(+3206.6%)
Revenue Growth (YoY)
-2.0%
PE vs Historical
-0.6 vs 0.6
CHEAP
Share & Embed Analysis
Last updated: August 27, 2026 9:19 PM ET
Data refreshes hourly during market hours. Next update: 10:19 PM
Data refreshes hourly during market hours. Next update: 10:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VNRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 43 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 58 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 35 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 49 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$108 | 43 HOLD |
